Emtriva Related Clinical Trials
An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects [Completed]
A 96 Week Study to Compare Tenofovir Versus Tenofovir Plus Emtricitabine for the Treatment of Chronic Hepatitis B [Active, not recruiting]
Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients [Completed]
Tenofovir Disoproxil Fumarate (DF) Versus Emtricitabine/Tenofovir DF Fixed-Dose in Subjects Resistant to Lamivudine [Recruiting]
Tenofovir Disoproxil Fumarate (DF)/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects [Active, not recruiting]
Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-Infected Patients With Tuberculosis [Not yet recruiting]
The Safety and Effectiveness of 524W91 [Completed]
Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection [Completed]
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B [Recruiting]
Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants [Active, not recruiting]
GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection [Active, not recruiting]
Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir DF in HIV-1-Infected Treatment Naive Adults [Active, not recruiting]
Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV [Recruiting]
Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women [Not yet recruiting]
Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects [Completed]
Efficacy and Tolerance of Peg-Interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV co-Infected Patients [Recruiting]
FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment [Completed]
Efficacy of Tenofovir and Emtricitabine in ARV-Naive Patients With HIV/HBV co-Infection [Active, not recruiting]
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens [Not yet recruiting]
A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes, and Eliminates a Drug), of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Nave HIV-1 Patients (Patients Have Never Received ARV Treatment). [Active, not recruiting]
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs [Active, not recruiting]
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Suspended]
Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs [Active, not recruiting]
Truvada Versus Truvada Plus HBIG in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant [Recruiting]
Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease. [Active, not recruiting]
Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF) [Not yet recruiting]
Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada [Recruiting]
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection [Recruiting]
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) [Recruiting]
Once-Daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl [Recruiting]
A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects [Withdrawn]
Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients [Recruiting]
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects [Completed]
Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA) [Recruiting]
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil [Active, not recruiting]
Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects [Recruiting]
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV [Active, not recruiting]
A Randomised, Open-Label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-Emtricitabine or Abacavir-Lamivudine: The STEAL Study [Recruiting]
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men [Recruiting]
Bone Mineral Density Substudy - An Ancillary Study to MTN-003 [Not yet recruiting]
GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance [Active, not recruiting]
Botswana TDF/FTC Oral HIV Prophylaxis Trial [Recruiting]
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults [Active, not recruiting]
Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) [Completed]
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis [Recruiting]
Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism [Recruiting]
BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada [Active, not recruiting]
"The Once A Day Protease Inhibitor Regimens" [Active, not recruiting]
Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875AM2) [Recruiting]
Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP [Completed]
SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection [Active, not recruiting]
Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients [Completed]
Safety and Efficacy Study of Switching From Epzicom to Truvada [Recruiting]
Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg [Recruiting]
TMC278-TiDP6-C209: A Clinical Trial in Treatment naïve HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine. [Recruiting]
BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes [Recruiting]
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-Infected Patients That Have Never Received Treatment. [Not yet recruiting]
Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children [Recruiting]
Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA) [Recruiting]
Three Month Course of Anti-HIV Medications for People Recently Infected With HIV
Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study [Recruiting]
ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial [Recruiting]
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV Infected Adults Being Treated for Tuberculosis [Recruiting]
Standard Antiretroviral Versus Multi-Class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01) [Recruiting]
Anti-HIV Medications for the Prevention of HIV Infection in Latin American Men Who Have Sex With Men [Not yet recruiting]
A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation [Active, not recruiting]
Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment [Recruiting]
Sex, Aging and Antiretroviral Pharmacokinetics [Recruiting]
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV [Recruiting]
Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy [Recruiting]
Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection [Not yet recruiting]
Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients [Recruiting]
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples [Recruiting]
NNRTI Versus PI Containing Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child Transmission of HIV [Recruiting]
Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in HIV Infected Naive Patients (NEwArT) [Recruiting]
Intensification With Enfuvirtide in Naive HIV-Infected Patients [Recruiting]
Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection [Recruiting]
Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV [Recruiting]
Preventing Sexual Transmission of HIV With Anti-HIV Drugs [Recruiting]
Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults [Not yet recruiting]
Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients [Not yet recruiting]
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women [Not yet recruiting]
The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens [Completed]
Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination [Completed]
A Study of HIV-Disease Development in Aging [No longer recruiting]
Effect of an Enfuvirtide-Based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults [Suspended]
Once-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-Limited Conditions [Recruiting]
A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy [No longer recruiting]
ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla [Recruiting]
Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy [Completed]
PREventing Progression of Adipose Tissue Redistribution [Recruiting]
When to Start Anti-HIV Drugs in Patients With Opportunistic Infections [Active, not recruiting]
Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults [Completed]
Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART [Completed]
A Study to Evaluate the Safety and Antiretroviral Activity of MK0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA(TM) [Active, not recruiting]
NO CT.GOV - Efficacy and Safety of Antiretroviral Therapy for Acute or Recent HIV-1 Infection in Zimbabwe and the United States [Recruiting]
Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients [Not yet recruiting]
Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV [Recruiting]
Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy [Recruiting]
ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial [Recruiting]
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection [Not yet recruiting]
|
